ENOS Antikörper (AA 1156-1183)

Produktnummer ABIN3032003

Produktdetails anti-ENOS Antikörper

Target: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Bindungsspezifität: AA 1156-1183

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser ENOS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)

Kreuzreaktivität (Details): Expected species reactivity: Mouse, Rat, Bovine, Pig

Aufreinigung: Antigen affinity purified

Immunogen: A portion of amino acids 1156-1183 from the human protein was used as the immunogen for this eNos antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: The stated application concentrations are suggested starting amounts. Titration of the eNos antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,Flow Cytometry: 1:10-1:50,Immunofluorescence: 1:10-1:50

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS pH 7.4 with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at 4°C for up to one month. For long term, aliquot the eNos antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Details zu ENOS

Target: ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))

Andere Bezeichnung: eNos (NOS3 Produkte)

Synonyme: ECNOS antikoerper, eNOS antikoerper, 2310065A03Rik antikoerper, Nos-3 antikoerper, ecNOS antikoerper, EC-NOS antikoerper, NOSIII antikoerper, cNOS antikoerper, NOS antikoerper, NOS3 antikoerper, eNos antikoerper, ENOS antikoerper, nitric oxide synthase 3 antikoerper, nitric oxide synthase 3, endothelial cell antikoerper, NOS3 antikoerper, Nos3 antikoerper, nos3 antikoerper

Hintergrund: ENos/NOS3 produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. [UniProt]

UniProt: P29474

Pathways: ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling